Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients
François Dépret(Université Paris Cité), Matthieu Legrand(University of California, San Francisco), Romain Sonneville(Université Claude Bernard Lyon 1), Nicolas Bréchot(Inserm), Oliver Hartmann, Bernard Cholley(Assistance Publique – Hôpitaux de Paris), Joachim Struck, Haikel Oueslati(Radboud University Nijmegen), Isabelle Rennuit(Hôpital Beaujon), Marie-Céline Fournier(Inserm), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Qin Lü(Shanghai Jiao Tong University), Samir Jaber(Inserm), Alain Cariou(Hôpital Cochin), Philippe Montravers(Université Claude Bernard Lyon 1), Étienne Gayat(Inserm), Charles Damoisel(Inserm), Bertrand Guidet(Inserm), Michaël Darmon(Inserm), Xavier Monnet(Bicêtre Hospital), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Marc Léone(Hôpital Nord), Jean‐Yves Lefrant(Université de Montpellier), Antoine Vieillard‐Baron(Inserm), Nicolas Deye(Inserm), Alexa Hollinger(University of Basel), Sébastien Pili‐Floury(Centre Hospitalier Universitaire de Besançon), Jacques Duranteau(Assistance Publique – Hôpitaux de Paris)
Cited by 79
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k